T2D Drug Disappoints in Heart Failure Study

ACC Conference Reporter

AHA 2015 | ORLANDO, FL — Liraglutide, a GLP-1 agonist that has been successfully used in diabetes management, was less successful for patients with severe heart failure -- with outcomes marginally worse compared to placebo, according to the results of a small study. Read More >>>

Keywords: AHA Annual Scientific Sessions

< Back to Listings